Curis Inc vs. Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CRIS | HALO | |
|---|---|---|
| Market Cap | $936,808 | $14.14 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| CRIS | HALO | |
|---|---|---|
| Short Interest | 68.09% | 9.79% |
HALO leads on 1 of 1 risk & sentiment factors.
Dig deeper: CRIS overview, CRIS financials, HALO overview, HALO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.